Gene Symbol | Gene ID | Gene Info |
---|---|---|
HES1
|
ENSG00000114315.3 | hes family bHLH transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_193857613_193857764 | HES1 | 3754 | 0.225086 | 0.80 | 9.4e-03 | Click! |
chr3_193852566_193852717 | HES1 | 1293 | 0.437742 | 0.79 | 1.2e-02 | Click! |
chr3_193855804_193856156 | HES1 | 2046 | 0.314617 | 0.77 | 1.5e-02 | Click! |
chr3_193857807_193857958 | HES1 | 3948 | 0.220687 | 0.75 | 1.9e-02 | Click! |
chr3_193852345_193852559 | HES1 | 1482 | 0.390311 | 0.75 | 2.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_159698543_159698722 | 0.67 |
ENSG00000243654 |
. |
20163 |
0.16 |
chr15_90756571_90757151 | 0.62 |
SEMA4B |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
8121 |
0.12 |
chr14_105433817_105433968 | 0.57 |
AHNAK2 |
AHNAK nucleoprotein 2 |
10802 |
0.16 |
chr9_139492781_139492932 | 0.57 |
ENSG00000252440 |
. |
4111 |
0.13 |
chr19_18284786_18284937 | 0.56 |
IFI30 |
interferon, gamma-inducible protein 30 |
384 |
0.75 |
chr2_75426550_75426809 | 0.55 |
TACR1 |
tachykinin receptor 1 |
147 |
0.97 |
chr22_39844539_39844690 | 0.53 |
MGAT3 |
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
8735 |
0.15 |
chr2_149633605_149633756 | 0.51 |
KIF5C |
kinesin family member 5C |
861 |
0.6 |
chr17_77775042_77775193 | 0.50 |
CBX8 |
chromobox homolog 8 |
215 |
0.81 |
chr1_55246980_55247131 | 0.49 |
TTC22 |
tetratricopeptide repeat domain 22 |
6410 |
0.14 |
chr21_40362052_40362203 | 0.49 |
ENSG00000272015 |
. |
95418 |
0.08 |
chr19_10341033_10341420 | 0.48 |
ENSG00000264266 |
. |
137 |
0.8 |
chr17_80175883_80176034 | 0.47 |
RP13-516M14.2 |
|
3855 |
0.12 |
chr10_43628367_43628518 | 0.47 |
CSGALNACT2 |
chondroitin sulfate N-acetylgalactosaminyltransferase 2 |
5492 |
0.26 |
chr12_125004479_125004643 | 0.47 |
NCOR2 |
nuclear receptor corepressor 2 |
1721 |
0.52 |
chr11_126256185_126256384 | 0.46 |
ST3GAL4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
5786 |
0.19 |
chr15_68966976_68967185 | 0.45 |
CORO2B |
coronin, actin binding protein, 2B |
42753 |
0.19 |
chr19_11670429_11670590 | 0.44 |
ZNF627 |
zinc finger protein 627 |
246 |
0.66 |
chr21_34602504_34602655 | 0.44 |
IFNAR2 |
interferon (alpha, beta and omega) receptor 2 |
92 |
0.96 |
chr5_134871333_134871641 | 0.43 |
NEUROG1 |
neurogenin 1 |
152 |
0.95 |
chr14_76287931_76288578 | 0.43 |
RP11-270M14.4 |
|
15300 |
0.24 |
chr20_19975685_19975836 | 0.43 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
22000 |
0.19 |
chr18_12271616_12271767 | 0.43 |
CIDEA |
cell death-inducing DFFA-like effector a |
17373 |
0.17 |
chr7_2680395_2680583 | 0.43 |
TTYH3 |
tweety family member 3 |
4677 |
0.21 |
chr19_33790905_33791151 | 0.42 |
CTD-2540B15.11 |
|
188 |
0.87 |
chr14_70038682_70038904 | 0.42 |
CCDC177 |
coiled-coil domain containing 177 |
761 |
0.71 |
chr17_79022713_79022864 | 0.42 |
BAIAP2 |
BAI1-associated protein 2 |
4374 |
0.15 |
chr9_139492984_139493135 | 0.41 |
ENSG00000252440 |
. |
3908 |
0.13 |
chr3_9214712_9214921 | 0.40 |
SRGAP3-AS2 |
SRGAP3 antisense RNA 2 |
19361 |
0.2 |
chr17_29822059_29822344 | 0.40 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
7075 |
0.14 |
chr17_80626738_80626935 | 0.39 |
ENSG00000266107 |
. |
653 |
0.57 |
chr15_70877190_70877341 | 0.39 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
117355 |
0.06 |
chr2_8727068_8727219 | 0.39 |
AC011747.7 |
|
88753 |
0.09 |
chr8_6372842_6373023 | 0.39 |
ANGPT2 |
angiopoietin 2 |
47633 |
0.16 |
chr20_58691613_58691835 | 0.38 |
C20orf197 |
chromosome 20 open reading frame 197 |
60744 |
0.14 |
chr9_6412690_6412898 | 0.38 |
UHRF2 |
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase |
529 |
0.8 |
chr2_65605736_65605887 | 0.38 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
927 |
0.57 |
chr16_88829190_88829356 | 0.38 |
RP5-1142A6.8 |
|
20044 |
0.07 |
chr12_8743487_8743638 | 0.38 |
ENSG00000238943 |
. |
1510 |
0.31 |
chr6_117197738_117198005 | 0.38 |
RFX6 |
regulatory factor X, 6 |
552 |
0.82 |
chr13_113764915_113765137 | 0.38 |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
4905 |
0.13 |
chr1_234675740_234675891 | 0.38 |
ENSG00000212144 |
. |
53206 |
0.11 |
chr10_45476036_45476374 | 0.37 |
C10orf10 |
chromosome 10 open reading frame 10 |
1947 |
0.22 |
chr18_9826704_9827051 | 0.37 |
ENSG00000242651 |
. |
3747 |
0.23 |
chr6_6694371_6694522 | 0.37 |
LY86-AS1 |
LY86 antisense RNA 1 |
71442 |
0.12 |
chr12_132106364_132106515 | 0.37 |
ENSG00000212154 |
. |
39169 |
0.19 |
chr22_34249799_34250025 | 0.36 |
LARGE |
like-glycosyltransferase |
7700 |
0.27 |
chr2_223170805_223170956 | 0.36 |
CCDC140 |
coiled-coil domain containing 140 |
3183 |
0.24 |
chr13_76060395_76060612 | 0.36 |
TBC1D4 |
TBC1 domain family, member 4 |
4253 |
0.26 |
chr16_136053_136204 | 0.36 |
Z69720.2 |
|
4501 |
0.11 |
chr3_79067067_79067218 | 0.36 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
552 |
0.86 |
chr7_1052092_1052243 | 0.36 |
ENSG00000199023 |
. |
10495 |
0.1 |
chr14_92912996_92913173 | 0.36 |
SLC24A4 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 |
7376 |
0.28 |
chr16_29302065_29302340 | 0.36 |
RP11-231C14.6 |
|
21469 |
0.17 |
chr10_111930415_111930653 | 0.35 |
MXI1 |
MAX interactor 1, dimerization protein |
36829 |
0.17 |
chr17_55478973_55479124 | 0.35 |
ENSG00000263902 |
. |
10514 |
0.26 |
chr2_113649251_113649402 | 0.34 |
IL37 |
interleukin 37 |
21222 |
0.16 |
chr22_25003244_25003451 | 0.34 |
GGT1 |
gamma-glutamyltransferase 1 |
241 |
0.9 |
chr2_16508691_16508842 | 0.34 |
ENSG00000251704 |
. |
128295 |
0.06 |
chrX_46421789_46422049 | 0.34 |
CHST7 |
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
11300 |
0.2 |
chr3_127521148_127521315 | 0.34 |
MGLL |
monoglyceride lipase |
18380 |
0.23 |
chr1_2467099_2467250 | 0.34 |
HES5 |
hes family bHLH transcription factor 5 |
5490 |
0.1 |
chr18_12630686_12630901 | 0.34 |
SPIRE1 |
spire-type actin nucleation factor 1 |
22291 |
0.14 |
chr19_55952161_55952312 | 0.34 |
SHISA7 |
shisa family member 7 |
1468 |
0.21 |
chr18_9016875_9017135 | 0.34 |
NDUFV2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
85623 |
0.08 |
chr5_115909413_115909607 | 0.34 |
SEMA6A |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
581 |
0.85 |
chr15_85457860_85458027 | 0.33 |
ENSG00000207037 |
. |
23810 |
0.13 |
chr9_140201196_140201347 | 0.33 |
NRARP |
NOTCH-regulated ankyrin repeat protein |
4568 |
0.11 |
chr13_78492863_78493091 | 0.33 |
EDNRB |
endothelin receptor type B |
11 |
0.95 |
chr14_96505703_96505974 | 0.33 |
C14orf132 |
chromosome 14 open reading frame 132 |
177 |
0.97 |
chr4_4854778_4854948 | 0.33 |
MSX1 |
msh homeobox 1 |
6530 |
0.29 |
chr2_206611565_206611716 | 0.33 |
AC007362.3 |
|
17037 |
0.25 |
chr2_85169512_85169765 | 0.33 |
KCMF1 |
potassium channel modulatory factor 1 |
28578 |
0.16 |
chr15_40627004_40627253 | 0.33 |
C15orf52 |
chromosome 15 open reading frame 52 |
3113 |
0.1 |
chr2_45169664_45169815 | 0.33 |
SIX3-AS1 |
SIX3 antisense RNA 1 |
727 |
0.48 |
chr7_105711867_105712305 | 0.33 |
SYPL1 |
synaptophysin-like 1 |
26222 |
0.22 |
chr22_39171379_39171530 | 0.33 |
SUN2 |
Sad1 and UNC84 domain containing 2 |
18694 |
0.08 |
chr7_1553312_1553509 | 0.32 |
AC102953.6 |
|
4347 |
0.16 |
chr21_43499892_43500191 | 0.32 |
UMODL1 |
uromodulin-like 1 |
8615 |
0.2 |
chr4_9500064_9500220 | 0.32 |
ENSG00000266246 |
. |
27445 |
0.14 |
chr5_76926843_76927107 | 0.32 |
OTP |
orthopedia homeobox |
8538 |
0.23 |
chr2_28491600_28491751 | 0.32 |
AC093690.1 |
|
41651 |
0.17 |
chr10_130008845_130008996 | 0.32 |
MKI67 |
marker of proliferation Ki-67 |
84271 |
0.11 |
chr9_139518117_139518268 | 0.32 |
ENSG00000252440 |
. |
21225 |
0.09 |
chr4_146655160_146655429 | 0.32 |
ZNF827 |
zinc finger protein 827 |
30913 |
0.18 |
chr16_81681030_81681181 | 0.32 |
CMIP |
c-Maf inducing protein |
2142 |
0.44 |
chr2_148601579_148601730 | 0.32 |
ACVR2A |
activin A receptor, type IIA |
432 |
0.86 |
chr2_127821817_127821968 | 0.31 |
BIN1 |
bridging integrator 1 |
42685 |
0.16 |
chr11_60793650_60793801 | 0.31 |
CD6 |
CD6 molecule |
17719 |
0.14 |
chr17_39949185_39949336 | 0.31 |
JUP |
junction plakoglobin |
6077 |
0.1 |
chr19_6237168_6237353 | 0.31 |
CTC-503J8.4 |
|
21908 |
0.13 |
chr18_76828740_76828968 | 0.31 |
ATP9B |
ATPase, class II, type 9B |
431 |
0.88 |
chr22_42696158_42696356 | 0.31 |
TCF20 |
transcription factor 20 (AR1) |
43365 |
0.14 |
chr2_197790785_197790936 | 0.31 |
PGAP1 |
post-GPI attachment to proteins 1 |
594 |
0.82 |
chr1_205474854_205475005 | 0.31 |
CDK18 |
cyclin-dependent kinase 18 |
999 |
0.52 |
chr12_66289957_66290108 | 0.31 |
RP11-366L20.2 |
Uncharacterized protein |
14085 |
0.17 |
chr8_8820802_8821008 | 0.31 |
ENSG00000207244 |
. |
1820 |
0.35 |
chr5_139702623_139702774 | 0.30 |
PFDN1 |
prefoldin subunit 1 |
19992 |
0.11 |
chr21_40382908_40383154 | 0.30 |
ENSG00000272015 |
. |
116322 |
0.06 |
chr22_40417826_40418098 | 0.30 |
FAM83F |
family with sequence similarity 83, member F |
12270 |
0.17 |
chr7_140098371_140098524 | 0.30 |
SLC37A3 |
solute carrier family 37, member 3 |
98 |
0.95 |
chr16_728352_728503 | 0.30 |
LA16c-313D11.9 |
|
1310 |
0.14 |
chr6_170501787_170501938 | 0.30 |
RP11-302L19.1 |
|
24121 |
0.21 |
chr6_106442714_106442865 | 0.30 |
ENSG00000200198 |
. |
90541 |
0.08 |
chr14_24744790_24744941 | 0.30 |
RABGGTA |
Rab geranylgeranyltransferase, alpha subunit |
3920 |
0.08 |
chr10_126754116_126754381 | 0.30 |
ENSG00000264572 |
. |
32809 |
0.18 |
chr16_1583661_1583861 | 0.30 |
TMEM204 |
transmembrane protein 204 |
187 |
0.58 |
chr8_28269829_28269980 | 0.30 |
ENSG00000207361 |
. |
4061 |
0.15 |
chr10_134331119_134331391 | 0.30 |
LINC01165 |
long intergenic non-protein coding RNA 1165 |
4698 |
0.23 |
chr19_11454879_11455424 | 0.30 |
CCDC159 |
coiled-coil domain containing 159 |
826 |
0.33 |
chr16_70728443_70728594 | 0.30 |
VAC14 |
Vac14 homolog (S. cerevisiae) |
978 |
0.47 |
chr3_188374207_188374358 | 0.29 |
ENSG00000264114 |
. |
25792 |
0.18 |
chr11_3022061_3022212 | 0.29 |
NAP1L4 |
nucleosome assembly protein 1-like 4 |
8529 |
0.12 |
chr17_4539926_4540256 | 0.29 |
ALOX15 |
arachidonate 15-lipoxygenase |
3086 |
0.15 |
chr18_57024288_57024928 | 0.29 |
LMAN1 |
lectin, mannose-binding, 1 |
2586 |
0.31 |
chr2_73496289_73496440 | 0.29 |
FBXO41 |
F-box protein 41 |
1679 |
0.29 |
chr8_22548474_22548625 | 0.29 |
ENSG00000253125 |
. |
886 |
0.41 |
chr11_57243945_57244096 | 0.29 |
RP11-624G17.3 |
|
987 |
0.35 |
chr12_125066547_125066772 | 0.29 |
NCOR2 |
nuclear receptor corepressor 2 |
14649 |
0.29 |
chr1_45279609_45279760 | 0.29 |
BTBD19 |
BTB (POZ) domain containing 19 |
5489 |
0.08 |
chr12_125093364_125093593 | 0.29 |
NCOR2 |
nuclear receptor corepressor 2 |
41468 |
0.21 |
chr19_49623573_49623831 | 0.29 |
PPFIA3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
1056 |
0.24 |
chr1_43405930_43406090 | 0.29 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
9214 |
0.19 |
chr3_47422515_47422816 | 0.29 |
PTPN23 |
protein tyrosine phosphatase, non-receptor type 23 |
155 |
0.52 |
chr6_15017519_15017967 | 0.28 |
ENSG00000242989 |
. |
95456 |
0.09 |
chr1_15417388_15417539 | 0.28 |
TMEM51 |
transmembrane protein 51 |
61565 |
0.12 |
chr11_57282126_57282281 | 0.28 |
SLC43A1 |
solute carrier family 43 (amino acid system L transporter), member 1 |
115 |
0.93 |
chr10_75576591_75576838 | 0.28 |
RP11-574K11.5 |
|
3438 |
0.11 |
chr1_154973632_154973783 | 0.28 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
1420 |
0.19 |
chr17_45949568_45949785 | 0.28 |
SP6 |
Sp6 transcription factor |
16436 |
0.1 |
chr18_13136764_13137008 | 0.28 |
RP11-794M8.1 |
|
79438 |
0.08 |
chr17_26708216_26708463 | 0.28 |
SARM1 |
sterile alpha and TIR motif containing 1 |
3780 |
0.08 |
chr17_79700663_79700814 | 0.28 |
SLC25A10 |
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
20266 |
0.08 |
chr1_1851146_1851342 | 0.28 |
TMEM52 |
transmembrane protein 52 |
532 |
0.68 |
chr11_126870671_126870822 | 0.28 |
KIRREL3 |
kin of IRRE like 3 (Drosophila) |
40 |
0.97 |
chr14_52781492_52781643 | 0.28 |
PTGER2 |
prostaglandin E receptor 2 (subtype EP2), 53kDa |
454 |
0.87 |
chr4_155412274_155412591 | 0.28 |
DCHS2 |
dachsous cadherin-related 2 |
54 |
0.98 |
chr14_105190142_105190317 | 0.28 |
ADSSL1 |
adenylosuccinate synthase like 1 |
294 |
0.85 |
chr7_2719075_2719226 | 0.28 |
AMZ1 |
archaelysin family metallopeptidase 1 |
6 |
0.98 |
chr14_35806722_35806916 | 0.28 |
PSMA6 |
proteasome (prosome, macropain) subunit, alpha type, 6 |
26780 |
0.19 |
chr12_6472314_6472494 | 0.28 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
909 |
0.44 |
chr18_9658030_9658181 | 0.28 |
ENSG00000212572 |
. |
40035 |
0.13 |
chr4_153944645_153944833 | 0.28 |
FHDC1 |
FH2 domain containing 1 |
80604 |
0.1 |
chr4_106473330_106473481 | 0.27 |
AC004066.3 |
|
107 |
0.8 |
chr11_75141053_75141204 | 0.27 |
KLHL35 |
kelch-like family member 35 |
108 |
0.95 |
chr16_15489705_15489922 | 0.27 |
MPV17L |
MPV17 mitochondrial membrane protein-like |
177 |
0.53 |
chr1_3073557_3073708 | 0.27 |
RP1-163G9.2 |
|
23359 |
0.22 |
chr11_316451_316602 | 0.27 |
RP11-326C3.11 |
|
2114 |
0.12 |
chr12_32739624_32739775 | 0.27 |
FGD4 |
FYVE, RhoGEF and PH domain containing 4 |
11761 |
0.26 |
chr16_8963146_8963297 | 0.27 |
RP11-77H9.6 |
|
113 |
0.77 |
chr20_1783720_1783871 | 0.27 |
SIRPA |
signal-regulatory protein alpha |
91359 |
0.07 |
chr19_56729074_56729225 | 0.27 |
ZSCAN5A |
zinc finger and SCAN domain containing 5A |
10510 |
0.1 |
chr21_37539073_37539317 | 0.27 |
DOPEY2 |
dopey family member 2 |
2362 |
0.21 |
chr1_27424839_27425237 | 0.27 |
SLC9A1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
55935 |
0.1 |
chr16_57418029_57418329 | 0.27 |
CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
7295 |
0.14 |
chr20_35490317_35490468 | 0.27 |
SOGA1 |
suppressor of glucose, autophagy associated 1 |
1697 |
0.32 |
chr17_7976584_7976755 | 0.27 |
AC129492.6 |
|
6131 |
0.1 |
chr7_20447658_20447906 | 0.27 |
ENSG00000200753 |
. |
30828 |
0.2 |
chr11_316119_316270 | 0.27 |
IFITM1 |
interferon induced transmembrane protein 1 |
2341 |
0.11 |
chr12_124875119_124875344 | 0.27 |
NCOR2 |
nuclear receptor corepressor 2 |
1861 |
0.47 |
chr7_150785539_150785789 | 0.27 |
AGAP3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
1510 |
0.21 |
chr20_24487977_24488128 | 0.27 |
SYNDIG1 |
synapse differentiation inducing 1 |
38217 |
0.23 |
chr11_2933384_2933685 | 0.27 |
SLC22A18AS |
solute carrier family 22 (organic cation transporter), member 18 antisense |
8564 |
0.12 |
chr16_81819777_81819928 | 0.27 |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
6989 |
0.3 |
chr7_6463832_6463983 | 0.27 |
DAGLB |
diacylglycerol lipase, beta |
23656 |
0.14 |
chr22_50743271_50743434 | 0.27 |
PLXNB2 |
plexin B2 |
2665 |
0.13 |
chr12_49175027_49175178 | 0.26 |
ADCY6 |
adenylate cyclase 6 |
2775 |
0.14 |
chr15_92972455_92972606 | 0.26 |
ENSG00000239197 |
. |
11753 |
0.21 |
chr9_101009625_101009776 | 0.26 |
TBC1D2 |
TBC1 domain family, member 2 |
8162 |
0.26 |
chr2_121493910_121494153 | 0.26 |
GLI2 |
GLI family zinc finger 2 |
208 |
0.97 |
chr21_44877468_44877619 | 0.26 |
SIK1 |
salt-inducible kinase 1 |
30535 |
0.22 |
chr22_41633966_41634117 | 0.26 |
CHADL |
chondroadherin-like |
1584 |
0.26 |
chr19_16832133_16832284 | 0.26 |
NWD1 |
NACHT and WD repeat domain containing 1 |
1348 |
0.35 |
chr3_5053541_5053692 | 0.26 |
BHLHE40-AS1 |
BHLHE40 antisense RNA 1 |
31970 |
0.16 |
chr4_74702269_74702510 | 0.26 |
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
32 |
0.97 |
chr19_49199324_49199475 | 0.26 |
FUT2 |
fucosyltransferase 2 (secretor status included) |
167 |
0.89 |
chr9_116311007_116311158 | 0.26 |
RGS3 |
regulator of G-protein signaling 3 |
12298 |
0.22 |
chr2_110089754_110089905 | 0.26 |
ENSG00000265965 |
. |
159748 |
0.04 |
chr10_33624786_33624937 | 0.26 |
NRP1 |
neuropilin 1 |
329 |
0.93 |
chr19_3434984_3435135 | 0.26 |
C19orf77 |
chromosome 19 open reading frame 77 |
43427 |
0.09 |
chr7_130126161_130126414 | 0.26 |
MEST |
mesoderm specific transcript |
92 |
0.72 |
chr8_33422808_33423410 | 0.26 |
RNF122 |
ring finger protein 122 |
1534 |
0.32 |
chr10_43601194_43601376 | 0.26 |
RET |
ret proto-oncogene |
28758 |
0.18 |
chr17_56013451_56013655 | 0.26 |
CUEDC1 |
CUE domain containing 1 |
19065 |
0.15 |
chr2_91777481_91777632 | 0.26 |
AC027612.6 |
|
65973 |
0.12 |
chr8_142127178_142127329 | 0.26 |
DENND3 |
DENN/MADD domain containing 3 |
124 |
0.97 |
chr7_25020987_25021202 | 0.26 |
OSBPL3 |
oxysterol binding protein-like 3 |
159 |
0.97 |
chr1_110198897_110199147 | 0.26 |
GSTM4 |
glutathione S-transferase mu 4 |
64 |
0.94 |
chr21_39644201_39644352 | 0.26 |
KCNJ15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
59 |
0.99 |
chr10_80993935_80994181 | 0.26 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
71917 |
0.11 |
chr19_36135685_36136013 | 0.26 |
ETV2 |
ets variant 2 |
1281 |
0.23 |
chr14_74036409_74036560 | 0.26 |
ACOT2 |
acyl-CoA thioesterase 2 |
721 |
0.52 |
chr17_79824826_79825163 | 0.26 |
RP11-498C9.3 |
|
603 |
0.43 |
chr18_46308841_46308992 | 0.26 |
RP11-484L8.1 |
|
52225 |
0.15 |
chr20_43245004_43245155 | 0.26 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
2130 |
0.23 |
chr7_157225515_157225699 | 0.26 |
AC006372.6 |
|
80381 |
0.09 |
chr19_1508442_1508669 | 0.25 |
CTB-25B13.9 |
|
174 |
0.82 |
chr16_68292014_68292165 | 0.25 |
RP11-96D1.7 |
|
681 |
0.44 |
chr20_60945361_60945512 | 0.25 |
LAMA5 |
laminin, alpha 5 |
3068 |
0.16 |
chr8_23410060_23410288 | 0.25 |
AC051642.1 |
|
10477 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 0.6 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.2 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.2 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.2 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.0 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.1 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.0 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.2 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.0 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.2 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.3 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.1 | GO:0009997 | negative regulation of heart induction by canonical Wnt signaling pathway(GO:0003136) negative regulation of cardioblast cell fate specification(GO:0009997) cardioblast cell fate commitment(GO:0042684) cardioblast cell fate specification(GO:0042685) regulation of cardioblast cell fate specification(GO:0042686) negative regulation of cardioblast differentiation(GO:0051892) cardiac cell fate specification(GO:0060912) negative regulation of heart induction(GO:1901320) negative regulation of cardiocyte differentiation(GO:1905208) regulation of cardiac cell fate specification(GO:2000043) negative regulation of cardiac cell fate specification(GO:2000044) |
0.0 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.0 | 0.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.3 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0072110 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.0 | 0.3 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.1 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.0 | 0.1 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0031650 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.2 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.3 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0060558 | regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.0 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.0 | 0.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0071071 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) regulation of phospholipid biosynthetic process(GO:0071071) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.1 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.0 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.1 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.0 | GO:1904748 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) regulation of apoptotic process involved in morphogenesis(GO:1902337) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) regulation of apoptotic process involved in development(GO:1904748) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.0 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.0 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.1 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.1 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.0 | 0.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.0 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0071732 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.0 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) iris morphogenesis(GO:0061072) |
0.0 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.0 | 0.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.0 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.0 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.0 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0051057 | positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0070307 | lens fiber cell development(GO:0070307) lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.5 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.2 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.2 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.2 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.0 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES | Genes involved in Transmembrane transport of small molecules |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |